Argenx
ARGX
#619
Rank
A$48.91 B
Marketcap
$793.53
Share price
1.31%
Change (1 day)
-2.10%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of September 2024 (TTM): 20.2

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 20.1894. At the end of 2024 the company had a P/S ratio of 16.0.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202416.0-13.14%
202318.4-63.94%
202251.0-17.67%
202162.0
201978.5-34.81%
2018120201.34%
201739.9
201425.2